BioMed Research International

Targeting Mitochondrial Function as a Strategy in Cancer Therapies


Publishing date
01 Jul 2020
Status
Closed
Submission deadline
28 Feb 2020

Lead Editor

1University of Minnesota, Minneapolis, USA

2Linkoping University, Linkoping, Sweden

3The Wistar Institute, Philadelphia, USA

4Karolinska Institutet, Stockholm, Sweden

This issue is now closed for submissions.

Targeting Mitochondrial Function as a Strategy in Cancer Therapies

This issue is now closed for submissions.

Description

Research studies have shown that cancer cells are extremely dependent on functional mitochondria, especially in the hypoxic area where cancer cells are relatively inactive (quiescent cell population). Cancer cells are dependent on functional mitochondria not only for energy production but also for anabolic reactions to provide the building blocks that are required and essential for cancer cell growth and proliferation, and also for crosstalk with other organelles to modulate the metabolism within the cancer cells. Therefore, targeting mitochondrial function has been considered a promising strategy for the treatment of cancer cells, especially the quiescent cell population, and many prospective findings and novel mitochondrial inhibitors have been reported. However, the mechanisms underlying mitochondrial regulation of tumor cells are still not fully understood and novel mitochondrial inhibitors with a good profile of absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) are still urgently required, especially for the population of quiescent cancer cells.

This Special Issue aims to collect original research and review articles relating to current studies on mitochondrial function and strategies for cancer treatment involving targeting mitochondria. Researchers and clinicians are invited to submit articles relating to basic, translational, or clinical research investigating the metabolism, regulation, and crosstalk of mitochondria in cancer cells or novel/repositioning drugs by targeting mitochondria in both proliferate and quiescent cancer cell populations. The submission of new methodologies to visualize dysfunctional mitochondria using new staining and analysis methods is also welcomed.

Potential topics include but are not limited to the following:

  • Alterations of mitochondrial biosynthesis and energy metabolism
  • Alterations of DNA (mtDNA), mRNA, or proteins, relating to mitochondria in cancer cells
  • Regulations of mitochondria relating to microRNA in cancer cells
  • The crosstalk of mitochondria with other organelles in cancer cells
  • Mitophagy in cancer cells
  • The control of reactive oxygen species (ROS) in cancer cells
  • The role of mitochondria in apoptosis in cancer cells
  • Mitochondrial function in cancerous stem cells
  • Novel/repositioning drugs targeting mitochondria of cancer cells
  • Strategies of cancer therapies by targeting mitochondrial function in cancer cells
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Check your manuscript for errors before submitting

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.